1999
DOI: 10.1007/s001340051022
|View full text |Cite
|
Sign up to set email alerts
|

Inhaled nitric oxide differentiates pulmonary vasospasm from vascular obstruction after surgery for congenital heart disease

Abstract: A trial of inhaled NO after cardiac surgery in neonates and infants may be useful to differentiate reversible pulmonary vasoconstriction from fixed anatomic obstruction and may provide useful information if temporary support with extracorporeal membrane oxygenation is considered. Failure to respond to inhaled NO should prompt further investigations to rule out a residual obstruction.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0
1

Year Published

2001
2001
2009
2009

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(12 citation statements)
references
References 15 publications
0
11
0
1
Order By: Relevance
“…It produces potent, selective pulmonary vasodilation that is independent of endothelial cell function. Therefore, it has been employed in the preoperative assessment of pulmonary hypertension, the perioperative management of pulmonary hypertension, and the postoperative assessment of pulmonary hypertension (2,4,5). Although many studies demonstrate a clear benefit in patient outcome with inhaled NO use, several safety concerns remain, including unpredictable and nonsustained responses to inhaled NO and a clinically significant rapid increase in pulmonary vascular resistance upon its acute withdrawal (1,(15)(16)(17).…”
Section: Discussionmentioning
confidence: 99%
“…It produces potent, selective pulmonary vasodilation that is independent of endothelial cell function. Therefore, it has been employed in the preoperative assessment of pulmonary hypertension, the perioperative management of pulmonary hypertension, and the postoperative assessment of pulmonary hypertension (2,4,5). Although many studies demonstrate a clear benefit in patient outcome with inhaled NO use, several safety concerns remain, including unpredictable and nonsustained responses to inhaled NO and a clinically significant rapid increase in pulmonary vascular resistance upon its acute withdrawal (1,(15)(16)(17).…”
Section: Discussionmentioning
confidence: 99%
“…During a previous study we noticed that lung transplant recipients when studied immediately following surgery exhale measurable amounts of NO that are higher than subjects following a similar degree of lung hypoperfusion for coronary artery bypass surgery [18]. Since lung transplant recipients have been reported to display marked pulmonary vascular sensitivity to inhaled NO [19] with inhaled NO being used to selectively reverse vasospasm following congenital heart surgery [20] we also studied lung transplant patients.…”
Section: Introductionmentioning
confidence: 99%
“…However, persistent pulmonary hypertension with reactive pulmonary vasoconstriction after the procedure may be a rare cause of cyanosis in PAIVS following RPVV. Inhaled nitric oxide has been proved to be a potent selective pulmonary vasodilator, which is effective in the management of postoperative pulmonary hypertension in patients with congenital heart disease 22-26. However, in spite of routine application in the clinical practice, nitric oxide inhalation has rarely been documented in the English literature in the postoperative care of patients with PAIVS treated by RPVV.…”
Section: Discussionmentioning
confidence: 99%